The Feasibility of Interventions to Reduce HIV Risk and Drug Use among Heterosexual Methamphetamine Users
- *Corresponding Author:
- Karen F. Corsi, ScD, MPH
University of Colorado
Denver School of Medicine 1741 Vine St
Denver, CO 80206, USA
E-mail: [email protected]
Received Date: April 12, 2012; Accepted Date: June 01, 2012; Published Date: June 04, 2012
Citation: Corsi1 KF, Lehman WE, Min SJ, Lance SP, Speer N, et al. (2012) The Feasibility of Interventions to Reduce HIV Risk and Drug Use among Heterosexual Methamphetamine Users. J AIDS Clinic Res S1:010. doi:10.4172/2155-6113.S1-010
Copyright: © 2012 Corsi1 KF, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This paper reports on a feasibility study that examined contingency management among out-of-treatment, heterosexual methamphetamine users and the reduction of drug use and HIV risk. Fifty-eight meth users were recruited through street outreach in Denver from November 2006 through March 2007. The low sample size reflects that this was a pilot study to see if CM is feasible in an out-of-treatment, street-recruited population of meth users. Secondary aims were to examine if reductions and drug use and risk behavior could be found. Subjects were randomly assigned to contingency management (CM) or CM plus strengths-based case management (CM/SBCM), with follow-up at 4 and 8 months. Participants were primarily White (90%), 52% male and averaged 38 years old. Eighty-three percent attended at least one CM session, with 29% attending at least fifteen. All participants reduced meth use significantly at follow-up. Those who attended more sessions submitted more stimulant-free urines than those who attended fewer sessions. Participants assigned to CM/SBCM attended more sessions and earned more vouchers than clients in CM. Similarly, participants reported reduced needle-sharing and sex risk. Findings demonstrate that CM and SBCM may help meth users reduce drug use and HIV risk.